Rapid Micro Biosystems (RPID) Operating Expenses (2020 - 2026)

Rapid Micro Biosystems' Operating Expenses history runs 7 years deep, the most recent figure standing at $14.2 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 17.89% year-over-year to $14.2 million; the TTM figure through Mar 2026 stood at $76.3 million (up 8.82% YoY), while the FY2025 annual figure was $81.0 million, up 3.86% from the prior year.
• Operating Expenses came in at $14.2 million for Q1 2026 at Rapid Micro Biosystems, down from $23.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $23.5 million in Q4 2025 to a low of $12.1 million in Q1 2025.
• A 5-year average of $19.2 million and a median of $19.6 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses soared 30.46% in 2022 and tumbled 39.32% in 2025, its largest moves.
• Rapid Micro Biosystems' Operating Expenses stood at $21.6 million in 2022, then declined by 14.37% to $18.5 million in 2023, then decreased by 0.42% to $18.4 million in 2024, then climbed by 27.35% to $23.5 million in 2025, then tumbled by 39.46% to $14.2 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $14.2 million, $23.5 million, and $19.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison